Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients
about
Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study.Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patientsHepatitis C virus infection and dialysis: 2012 update.Management of hepatitis C virus infection in hemodialysis patients.Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control studyPrevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine.Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study.Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.Management of hepatitis C in patients with chronic kidney disease.Management of the kidney transplant patient with chronic hepatitis C infectionHepatitis C in hemodialysis patientsIncidence of CMV-HCV coinfection in renal transplant recipient.Incidence and prevalence of hepatitis B and hepatitis C viruses in hemodialysis patients in LebanonEvidence of association between hepatitis C virus genotype 2b and nosocomial transmissions in hemodialysis centers from southern Brazil.Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures.Hepatitis B and C in dialysis units in Kosova.Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients.Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients.Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.Hepatitis C infection and related factors in hemodialysis patients in china: systematic review and meta-analysis.Prevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran.Treatment of hepatitis C virus infection in patients with end-stage renal disease.An archived serum sample as a clue for identifying the primary source of a nosocomial hepatitis C virus outbreak in a haemodialysis unit.Hepatitis C virus infection in end-stage renal disease and kidney transplantation.Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study.High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis.Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients.Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis.Long-term Patient and Graft Survival of Kidney Transplant Recipients with Hepatitis C Virus Infection in the United States.Hepatocellular carcinoma in hemodialysis patients.Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil.Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China.Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients.Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR.Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis population.Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines.A shield against a monster: Hepatitis C in hemodialysis patients.YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.[Identification of the cutoff value for serum alanine aminotransferase in hepatitis C screening of patients with chronic renal failure on hemodialysis].Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study.
P2860
Q33277945-5CC7D896-98A3-4A93-B0C8-EB147D367083Q33592762-1AD57D7E-3BDE-40FC-9DE8-EC04BB84426AQ33710828-A7F42B5A-F3A2-417C-9057-9B475B8D1273Q33845152-C3BE234A-466F-4D4C-96D5-AAF09AFBB28AQ33867045-D86E3666-CB00-4677-9C96-2BD6708E2D51Q34142181-7870D26D-9531-4749-992D-5D7B4EBC0591Q34352780-8BCBC193-0635-4591-9A17-1CD3B5DB1B2FQ34452614-D4A1A258-105D-4074-AB8F-63E56154EB94Q34932338-AE507D2C-B9D7-4837-8C31-470A6E9B2A3CQ34988932-9EE703A3-2990-4CC0-AEC8-1119437794CBQ35237329-C130EA3E-AD13-4326-8568-BE5E6398DD0FQ35919439-84C78182-0384-4403-9604-20D2A9CC827FQ36447917-D8CC6949-0EDB-4A7B-A7D3-4976D6977805Q36923004-7C8C0209-7931-49AC-AB6D-38E7493531C9Q37088857-BFD9FC2E-8BA1-4965-A77A-5558CCC52ECEQ37223538-577D622F-24FF-4FD4-8D4C-8E53769B5236Q37506465-6962BA5A-4298-4DFF-9911-809978353647Q37510993-4FC9FE4E-25EF-4231-ACD6-7AC283260B99Q37511212-57224ED0-4D30-448B-8517-FD0761EBAE15Q37617380-A0E114CD-8F53-4B06-B17B-BB6033DC3654Q37632074-FD6CFDDA-1BFC-4063-AC40-94B77C6D74C4Q37831965-F5DE59A4-3190-4FC7-96D3-74B8BFE12099Q38204301-754BA992-31D0-4B9E-8A3A-EB1A58692013Q38213956-50B87555-3950-4FF0-AB90-69C8F8FCE9CBQ38621703-D17FC546-BBC7-43B2-B334-DAB73B6C52D9Q38989981-6E23CCA5-A177-4A2F-8B71-6AB4CB96B493Q39144402-3217BB1A-2CC4-4C49-8467-D05C369CD8B5Q39488889-A70C7235-E71B-4EAB-BDF6-0D29031F8504Q41924793-E5D07BF8-BBE3-404C-88DE-2A9AB037BBB8Q42654107-FA5A1A52-9925-4CCB-AB1B-8958CD9AFB08Q42980341-B06D895F-E870-4DBF-B718-97FD77D581CAQ42988519-3E90698E-3583-452B-9684-5DE9555C5B87Q42992718-DB9F1D2A-7418-4056-9D2E-E690C1227AC7Q42992771-E68CB3E2-22B4-4EB2-9CE9-273B246EE743Q42997619-0C0ABD3A-58AD-496D-9B72-AEA61FECF04DQ43100447-809DFB03-ACAF-4F20-AFF9-E54AD419F1D7Q43165948-9DAF2D0A-C006-483E-9AF9-89C711E9E20DQ44809014-EFB01622-CF54-4170-85E3-1613091CB104Q44813066-478853E5-4B4F-4191-B598-C233A04D7890Q45423231-26E48255-43FE-409D-BB02-03BF8BB37136
P2860
Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prevalence and risk factors of ...... icentre study in 2796 patients
@ast
Prevalence and risk factors of ...... icentre study in 2796 patients
@en
Prevalence and risk factors of ...... icentre study in 2796 patients
@nl
type
label
Prevalence and risk factors of ...... icentre study in 2796 patients
@ast
Prevalence and risk factors of ...... icentre study in 2796 patients
@en
Prevalence and risk factors of ...... icentre study in 2796 patients
@nl
prefLabel
Prevalence and risk factors of ...... icentre study in 2796 patients
@ast
Prevalence and risk factors of ...... icentre study in 2796 patients
@en
Prevalence and risk factors of ...... icentre study in 2796 patients
@nl
P2093
P2860
P356
P1433
P1476
Prevalence and risk factors of ...... icentre study in 2796 patients
@en
P2093
G Leimenstoll
H Hinrichsen
H Schrader
U R Fölsch
W E Schmidt
P2860
P304
P356
10.1136/GUT.51.3.429
P407
P577
2002-09-01T00:00:00Z